Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 61

Results For "MS"

5444 News Found

Free HLA typing for children with thalassaemia launched in India
Healthcare | May 07, 2026

Free HLA typing for children with thalassaemia launched in India

The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia


Dr. Mansukh Mandaviya to launch nationwide Free Annual Health Check-Up today
Policy | May 07, 2026

Dr. Mansukh Mandaviya to launch nationwide Free Annual Health Check-Up today

These check-ups will be conducted through ESIC’s extensive network of hospitals, with a focus on early diagnosis, preventive healthcare, and continuous health monitoring


Neuland Labs and LIR Life partner on next-gen transdermal GLP-1 obesity therapy platform
News | May 07, 2026

Neuland Labs and LIR Life partner on next-gen transdermal GLP-1 obesity therapy platform

LIR Life is working on a patch-based, transdermal delivery system for GLP-1 therapies targeting obesity


CARBOGEN AMCIS Shanghai site clears unannounced NMPA GMP inspection
News | May 07, 2026

CARBOGEN AMCIS Shanghai site clears unannounced NMPA GMP inspection

Successful inspection outcome strengthens company’s regulatory compliance and manufacturing standards in China


Experts call for easing access to 2mg and 4mg nicotine replacement therapies
Public Health | May 07, 2026

Experts call for easing access to 2mg and 4mg nicotine replacement therapies

With 267 million tobacco users, improving access to evidence-based cessation tools is seen as critical


China poised to launch world’s first CAR-T therapy for gastric cancer
Biopharma | May 07, 2026

China poised to launch world’s first CAR-T therapy for gastric cancer

As per GlobalData, CARsgen’s satri-cel could mark a major breakthrough in solid tumor treatment as competition intensifies


Neurobion introduces nerve pain relief cream
Healthcare | May 07, 2026

Neurobion introduces nerve pain relief cream

The formulation contains 0.075% Capsaicin, a clinically proven ingredient along with menthol, camphor and eucalyptus oil


GRIN Therapeutics launches Phase 3 beeline study in Europe for radiprodil in GRIN-NDD
Clinical Trials | May 07, 2026

GRIN Therapeutics launches Phase 3 beeline study in Europe for radiprodil in GRIN-NDD

This is an exciting and meaningful milestone for GRIN Therapeutics


Laurus Labs Q4 profit rises to Rs. 279 crore, FY26 revenue up 23%
News | May 06, 2026

Laurus Labs Q4 profit rises to Rs. 279 crore, FY26 revenue up 23%

The company reported robust revenue and profit growth for FY26, supported by strong CDMO performance, improving margins, and expansion across advanced manufacturing platforms